Member of the PNOC (Pediatric Neurooncology consortium) and as accredited member in the PNOC
CO/PI of BMT and Neuroncology study team
Children cancer hospital Egypt
01.2022 - Current
Professor of Pediatric Hematology and Oncology
National Cancer Institute, Cairo University
01.2019 - Current
Consultant of bone marrow transplantation
Children’ Cancer Hospital Egypt - 57357 (CCHE - 57357)
01.2014 - Current
Member of the bone marrow transplantation study team in CCHE
Consultant of Pediatric Hematology and Oncology
Children’ Cancer Hospital Egypt - 57357 (CCHE - 57357)
01.2013 - Current
Lecturer of Pediatric Hematology and Oncology
National Cancer Institute, Cairo University
01.2013 - 01.2020
Attending of Pediatric Hematology and Oncology
National Cancer Institute, Cairo University
01.2008 - 01.2012
Attending of Pediatric Hematology and Oncology
Children’s Cancer Hospital Egypt - 57357 (CCHE - 57357)
01.2008 - 01.2012
Internship
Cairo University Hospitals
01.2004 - 01.2005
Education
Doctorate degree of Science (DSc) - Pediatric Hematology/Oncology
Cairo University
01.2013
Masters - Pediatric Oncology
Cairo University
01.2008
Bachelor of Medicine & Surgery (M. B., B. Ch.) - Medicine
Cairo University
01.2003
Skills
Low grade glioma trials using targeted therapy
Using autologous bone marrow transplant in pediatric brain tumors especially infantile medulloblastoma
Allo transplant in haematology malignancies
Certification
2003-present Egyptian Ministry of Health and Population: Unrestricted medical license number 14312
Awards
1997-2003 Dean’s Honor List: Kasr El-Aini School of Medicine: Cairo University, Cairo, Egypt., 2003 Medical Doctoral Degree Graduation Honor of Excellence: Faculty of Medicine, Cairo University, Cairo, Egypt., 2008 Masters Degree Honor of Excellence: Children’s Hospital, Cairo University, Cairo, Egypt., 2013 Doctorate degree of Science (DSc) in Pediatric Hematology/Oncology; Cairo University, Cairo, Egypt.
Publications
BONE MARROW ABLATIVE CHEMOTHERAPY ASSOCIATED WITH IMPROVED OUTCOMES AMONG PATIENTS WITH RELAPSED CENTRAL NERVOUS SYSTEM NON-GERMINOMATOUS GERM CELL TUMORS: Neur Oncology 25(Supplement_1):i34-i35 DOI:10.1093/neuoncology /noad073.136.
RARE-08. MULTI-INSTITUTIONAL ANALYSIS OF PEDIATRIC RELAPSED/REFRACTORY CENTRAL NERVOUS SYSTEM GERMINOMA: Neuro-Oncology 25(Supplement_1):i35-i35:DOI:10.1093/neuoncology /noad073.137
Prognostic factors affecting infantile medulloblastoma outcomes in the molecular era: a 12-year single-center experience from Egypt : March 202 Future Oncology 19(1)DOI:10.2217/fon-2022-0559
Efficacy of different salvage regimens in progressive unresectable pediatric low-grade glioma September 2022,Oncology Letters 24(5) DOI:10.3892/ol.2022.13527
Palliative and end-of-life symptoms management for children with diffuse intrinsic pontine glioma: February 2022, Future Oncology 18(16),DOI:10.2217/fon-2021-1455
Prognostic factors and outcome of pineoblastoma: 10 years single-center experience: December 2021,Journal of the Egyptian National Cancer Institute 33(1),DOI:10.1186/s43046-021-00083-3
The Impact of Pretransplant Disease Characteristics on the Outcome of Autologous Stem Cell Transplantation for Neuroblastoma with High-Risk Features: A Retrospective Model from a Limited Resources Country: January 2019,Journal of Cancer Therapy 10(06):422-432 DOI:10.4236/jct.2019.106035
Association of Aggresomes with Survival Outcomes in Pediatric Medulloblastoma: August 2019, Scientific Reports 9(1)DOI:10.1038/s41598-019-49027-x
Outcome of High-risk Langerhans Cell Histiocytosis (LCH) in Egyptian Children, Does Intermediate-dose Methotrexate Improve the Outcome?: September 2018,Journal of Pediatric Hematology/Oncology 41(8),DOI:10.1097/MPH.0000000000001314
Risk stratification of pediatric high-grade glioma: a newly proposed prognostic score: December 2019,Child's Nervous System 35(12),DOI:10.1007/s00381-019-04257-2
Prevalence and prognostic impact of BRAF V600E mutation and CDKN2A deletion in pediatric high-grade glioma, Frontiers in Oncology 15,august 2025 DOI: 10.3389/fonc.2025.1537268
RARE-08. MULTI-INSTITUTIONAL ANALYSIS OF PEDIATRIC RELAPSED/REFRACTORY CENTRAL NERVOUS SYSTEM GERMINOMA, Neur Oncology 25(Supplement_1):i34-i35 DOI:10.1093/neuoncology /noad073.136.
Does Salvage Chemotherapy Regimen Intensity Embark on Clearance of Bone Marrow Neuroblastoma?: May 2019: Asian Pacific Journal of Cancer Prevention 20(5):1519-1524 DOI:10.31557/APJCP.2019.20.5.1519
Timeline
PI
CCHE site
03.2023
CO/PI of BMT and Neuroncology study team
Children cancer hospital Egypt
01.2022 - Current
Professor of Pediatric Hematology and Oncology
National Cancer Institute, Cairo University
01.2019 - Current
Consultant of bone marrow transplantation
Children’ Cancer Hospital Egypt - 57357 (CCHE - 57357)
01.2014 - Current
Consultant of Pediatric Hematology and Oncology
Children’ Cancer Hospital Egypt - 57357 (CCHE - 57357)
01.2013 - Current
Lecturer of Pediatric Hematology and Oncology
National Cancer Institute, Cairo University
01.2013 - 01.2020
Attending of Pediatric Hematology and Oncology
National Cancer Institute, Cairo University
01.2008 - 01.2012
Attending of Pediatric Hematology and Oncology
Children’s Cancer Hospital Egypt - 57357 (CCHE - 57357)
01.2008 - 01.2012
Internship
Cairo University Hospitals
01.2004 - 01.2005
Bachelor of Medicine & Surgery (M. B., B. Ch.) - Medicine
Cairo University
Doctorate degree of Science (DSc) - Pediatric Hematology/Oncology
Intern at Sitel- Information Technology Service Delivery, ETON Site, IT Site Engineer DepartmentIntern at Sitel- Information Technology Service Delivery, ETON Site, IT Site Engineer Department